Horie Akeyo, Hiki Yoshiyuki, Odani Hiroko, Yasuda Yoshinari, Takahashi Mami, Kato Masashi, Iwase Hitoo, Kobayashi Yutaka, Nakashima Izumi, Maeda Kenji
Department of In-Home Medicine, Nagoya University School of Medicine, Nagoya, Aichi, Japan.
Am J Kidney Dis. 2003 Sep;42(3):486-96. doi: 10.1016/s0272-6386(03)00743-1.
Human serum immunoglobulin A1 (IgA1) has a unique mucine-like structure in its hinge region that contains O-glycans and proline-rich peptides. We previously reported the under-O-glycosylation of the hinge in serum IgA1 and deposited IgA1 in glomeruli (glomerular IgA1) in IgA nephropathy. The clinical development and exacerbation of IgA nephropathy frequently are preceded by episodes of upper respiratory tract infections. Therefore, tonsils, which represent the predominant immunocompetent tissue of the upper respiratory tract, may be related to the pathogenesis of IgA nephropathy. In this study, we investigated the O-glycan structure of IgA1 produced by tonsillar lymphocytes (tonsillar IgA1), suspecting that tonsillar IgA1 is one of the origins of glomerular IgA1 in patients with IgA nephropathy.
Extracted tonsils were obtained from 7 patients with IgA nephropathy and 5 patients with chronic tonsillitis as controls. Tonsillar lymphocytes separated from extracted tonsils were cultured for 7 days, and IgA1 in the culture medium was purified. The varieties of O-glycans in tonsillar IgA1 were determined from the molecular weights measured by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
A significant increase in the percentage of asialo-agalacto type O-glycans was found in tonsillar IgA1 in 4 of 7 patients with IgA nephropathy (57.1%) compared with controls. Between the IgA nephropathy and control groups, the difference was statistically significant (P = 0.047).
This study provides precise information about the structure of O-glycans in tonsillar IgA1 in patients with IgA nephropathy. Our results suggest that tonsils produced the underglycosylated IgA1 molecules in patients with IgA nephropathy.
人血清免疫球蛋白A1(IgA1)在其铰链区具有独特的黏蛋白样结构,该结构包含O-聚糖和富含脯氨酸的肽段。我们之前报道过,IgA肾病患者血清IgA1铰链区存在O-糖基化不足现象,且肾小球中有IgA1沉积(肾小球IgA1)。IgA肾病的临床进展和病情加重常常在上呼吸道感染发作之后出现。因此,作为上呼吸道主要免疫活性组织的扁桃体,可能与IgA肾病的发病机制有关。在本研究中,我们调查了扁桃体淋巴细胞产生的IgA1(扁桃体IgA1)的O-聚糖结构,怀疑扁桃体IgA1是IgA肾病患者肾小球IgA1的来源之一。
从7例IgA肾病患者和5例慢性扁桃体炎患者(作为对照)中获取切除的扁桃体。将从切除的扁桃体中分离出的扁桃体淋巴细胞培养7天,然后纯化培养基中的IgA1。通过基质辅助激光解吸/电离飞行时间质谱法测量分子量,从而确定扁桃体IgA1中O-聚糖的种类。
7例IgA肾病患者中有4例(57.1%)的扁桃体IgA1中,去唾液酸-去半乳糖型O-聚糖的百分比与对照组相比显著增加。IgA肾病组和对照组之间的差异具有统计学意义(P = 0.047)。
本研究提供了有关IgA肾病患者扁桃体IgA1中O-聚糖结构的精确信息。我们的结果表明,扁桃体产生了IgA肾病患者中糖基化不足的IgA1分子。